Returning guest, Dr. Neil Skolnik, MD, Professor of Family and Community Medicine at Jefferson Health and practicing primary care physician discusses chronic kidney disease and the importance of primary care practitioners to educate their patients about recognizing the signs of this “Invisible Disease.” Dr. Skolnik covers the main causes, signs, existing treatment options, and the new guidelines for estimated Glomerular Filtration Rate (eGFR).
Melissa Rogne, Founder and President of Chapter Aesthetic Studio discusses their expansion over the next two years with a unique focus on communities where medical aesthetics options are limited, giving more people access to high-quality, non-surgical cosmetic treatments.
Hong Sun, M.D., Ph.D. is a Senior Director, Global Compound Development Team Leader for the Neuroscience Therapeutic Area at Janssen Research & Development, LLC. In this segment, she discusses how Janssen is working to address the unmet needs of patients impacted by rare diseases, including rare neuromuscular conditions like myasthenia gravis (MG), through the Company’s autoantibody research. Janssen is currently investigating nipocalimab, which uses a unique mechanism of action to accelerate the removal of pathogenic autoantibody in patients affected by MG.
Afsaneh Barzi, MD, PhD, associate professor of gastrointestinal oncology at City of Hope discusses advancements in treating colorectal cancer (CRC), especially since colorectal cancer rates are rising in younger adults. She also speaks about her role at AccessHope, a company which delivers a revolutionary cancer benefit that connects employees, regardless of their location, with cancer specialists, so they can receive the latest cancer knowledge from nationally recognized comprehensive cancer centers like City of Hope.
Dr. Sumanta (“Monty”) Pal, Professor, Department of Medical Oncology & Therapeutics Research; Co-director, Kidney Cancer Program at City of Hope, a cancer research and treatment organization, discusses a recent ph 1 study published in “Nature Medicine” (28 Feb 22) that links enhanced anti-tumor response in kidney cancer patients with treatment using both immunotherapy and a live biotherapeutic product that adjusts gut bacteria or the microbiome. Fecal matter transplants appear to have promise and have gained some news traction in recent years, but it is an arduous process and appears to come with riskier side effects than a bacterial product that can be taken orally, which is a technique this study investigates.
In the coming months, the FDA is expected to finalize its proposed rule to make certain hearing aids available over the counter, which will allow consumers to buy hearing aids without the supervision of a medical professional. While this new category may increase access, it has the potential to lead to consumer confusion. This is why seeing a hearing care professional before making such an important decision is still the most critical first step someone concerned about their hearing health should take in the process. Kate Carr, President of the Hearing Industries Association (HIA), which represents the leading hearing aid manufacturers in the world, and Dr. Thomas Powers, an audiologist, professor and researcher, discusses the upcoming change, what it means for hearing health and what listeners need to know about hearing loss and treatment.
Dr. Eleni Efstathiou, MD, PhD, Section Chief of Genitourinary Medical Oncology at Houston Methodist Oncology Partners and an investigator on the Phase 3 MAGNITUDE study discusses new data showing that first-line use of niraparib in combination with abiraterone acetate (Zytiga) plus prednisone, significantly improves progression-free survival in patients with metastatic castration-resistant prostate cancer and homologous recombination repair gene alterations. These data were presented at the American Society of Clinical Oncology’s Genitourinary Cancers Symposium 2022.
Returning guest, Dr. Mitzi Joi Williams, board-certified neurologist, fellowship-trained multiple sclerosis specialist and Founder and CEO of the Joi Life Wellness Group Multiple Sclerosis Center in Atlanta, and Christine Ha, the first blind contestant and winner of the third season of MasterChef, who lives with neuromyelitis optica spectrum disorder (NMOSD) discuss NMOSD, a rare inflammatory disease that affects the optic nerves and spinal cord and often mistaken for multiple sclerosis. They have partnered to encourage people to advocate for themselves and their health via a new campaign called NMOSD Won’t Stop Me. People impacted by NMOSD and their loved ones are encouraged to submit their stories and learn more on NMOSDWontStopMe.com.
Robyn Knecht, Director of Counseling Services at the Saint Joseph’s Indian School in South Dakota discusses the school; equine therapy and the benefits it provides; how St. Joseph’s equine therapy program is making a difference in the lives of Native American youth, and the significance of the horse in Native American culture.
Robyn Knecht, Director of Counseling Services at the Saint Joseph’s Indian School in South Dakota discusses the school; why Native Americans suffer disproportionately from things like addiction, mental illness, and suicide; and how St. Joseph’s helps students overcome some of these challenges.